South Korea
“Pan Orion Invests $415M in Korean Biotech LegoChem, Secures Majority Stake”
Once finalized, LegoChem will become part of Orion’s corporate family but will retain its current frameworks and management.
Lunit Secures $150 Million in Capital Increase
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of a significant paid-in capital increase of $150 million.
Orum Therapeutics Announces Acquisition of ORM-6151 Program by Bristol Myers Squibb
Under this transaction, Bristol Myers Squibb has acquired Orum’s ORM-6151 program for an upfront payment of $100 million, and Orum Therapeutics is eligible to receive milestone payments for a total deal value of $180 million. Further details were not disclosed.
Chong Kun Dang partners with Novartis in historic $1.3 billion deal
Pharmaceutical company Chong Kun Dang signed a $1.3-billion technology transfer agreement with Novartis for its rare genetic disease treatment candidate.
Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development
Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South Korean biotech company to accelerate multi-specific protein development, at a signing ceremony held in Optics Valley Wuhan, Hubei Province on the 19th of September.
Celltrion Group to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Celltrion Group today announced that the company will be attending the Morgan Stanley 21st Annual Global Healthcare Conference in New York City on Monday, September 11, 2023. Jungjin Seo, Chairman, will be speaking in a fireside chat at 3:35 p.m. ET.
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, unveiled today its 'Open Innovation Program powered by Seegene (Open Innovation Program)' in partnership with Springer Nature, a world-leading provider of services to the research community. The inaugural program is available globally and is the first step in empowering experts, scientists, and clinicians to develop syndromic quantitative PCR (qPCR) assays across all fields.
Alteogen’s Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile
Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages.
IVI and the Madagascar Institute for Vaccine Research launch typhoid conjugate vaccine campaign for infants and children
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the Madagascar Institute for Vaccine Research (MIVR) at the University of Antanararivo held a ceremony today to launch a mass vaccination campaign against typhoid in the Arivonimamo and Antananarivo-Atsimondrano districts of Madagascar.
GC Biopharma to organize “Donate Blood with Love”, a healthy way of giving back to the community
All executives and employees of GC Biopharma, a South Korean biopharmaceutical company, rolled up their sleeves to practice ESG and social value.
